{ "id": "RL32549", "type": "CRS Report", "typeId": "REPORTS", "number": "RL32549", "active": false, "source": "EveryCRSReport.com", "versions": [ { "source": "EveryCRSReport.com", "id": 317405, "date": "2004-08-27", "retrieved": "2016-04-07T20:09:45.572068", "title": "Project BioShield: Legislative History and Side-by-Side Comparison of H.R. 2122, S. 15, and S. 1504", "summary": "Few effective countermeasures currently exist to deal with chemical, biological, radiological,\nand\nnuclear terror agents. In early 2003, the Bush administration proposed Project BioShield to stimulate\nthe development of such countermeasures and to procure them for the Strategic National Stockpile\n(SNS). Congress considered three bills that incorporated much of the administration's proposal:\n S. 15 (Gregg), H.R. 2122 (Tauzin), and S. 1504 (Gregg). \n H.R. 2122 passed the House on July 16, 2003. S. 15 passed the Senate on\nMay 25, 2004 in an amended form similar to H.R. 2122 . This version of S. 15\npassed the House on July 14, 2004. President Bush signed S. 15 into law as the Project\nBioShield Act of 2004 ( P.L. 108-276 ) on July 21, 2004. \n Although many of the details of Project BioShield changed during Congressional consideration,\nall the proposals shared similar key provisions. Each bill would have provided expedited hiring,\nprocurement, and grant awarding procedures for bioterrorism-related products and services. Each\nbill would have provided a market guarantee for countermeasure producers by allowing the \nSecretary of Health and Human Services (HHS) to contract to procure countermeasures still in\ndevelopment. Thus, several years before a company plans to be able to deliver a countermeasure,\nthe company would have been assured that if they successfully develop the countermeasure the\ngovernment is obligated to purchase a set amount of it at a set price. Each bill would have\nauthorized the HHS Secretary to allow the emergency use of countermeasures that lack Food and\nDrug Administration approval.\n Congress changed many important aspects of the Administration's proposal. The most\nimportant change related to the funding mechanism. The Administration requested a permanent,\nindefinite appropriation, to be spent at the President's discretion, for the purchase of\ncountermeasures. The enacted version of Project BioShield authorizes the appropriation of $5.593\nbillion for FY2004-FY2013. The Department of Homeland Security (DHS) Appropriations Act\n( P.L. 108-90 ) appropriated this amount.\n The Project BioShield Act of 2004 ( P.L. 108-276 ) also: transfers the SNS from DHS to HHS,\npermits procurement of countermeasures with commercial markets, permits countermeasure\nprocurement contracts to be written up to eight years before countermeasures are expected to be\ndeliverable, and authorizes appropriations to allow DHS to improve its ability to perform threat\nanalysis. A provision that would have allowed HHS to develop countermeasures directly was\nexcluded from the enacted version Project BioShield.\n This report will not be updated. For more analysis and the current status of Project BioShield,\nsee CRS Report RS21507 , Project BioShield , by Frank Gottron.", "type": "CRS Report", "typeId": "REPORTS", "active": false, "formats": [ { "format": "HTML", "encoding": "utf-8", "url": "http://www.crs.gov/Reports/RL32549", "sha1": "1298506761f7a1e988f6501801a9a195e5dbbf39", "filename": "files/20040827_RL32549_1298506761f7a1e988f6501801a9a195e5dbbf39.html", "images": null }, { "format": "PDF", "encoding": null, "url": "http://www.crs.gov/Reports/pdf/RL32549", "sha1": "4bacd33ddfe45c5ab7e7b487d6563981074b577e", "filename": "files/20040827_RL32549_4bacd33ddfe45c5ab7e7b487d6563981074b577e.pdf", "images": null } ], "topics": [] } ], "topics": [ "Appropriations", "Health Policy", "Intelligence and National Security", "National Defense" ] }